Buy Crypto
Pay with
USD
USD
Buy & Sell
Hot
Supports Visa, Mastercard, SEPA & more
P2P
0 Fees
Flexible trading, zero fees
Gate Card
Use your crypto for payments worldwide
Markets
Trade
Basic
Advanced
Futures
Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Stocks
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Earn
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Investment
Square
Square
Post, share, and explore crypto trends
Live
moments live
Live crypto market analysis
Chat
Chat with crypto traders
News
What is happening in crypto
flower_head
More
Promotions
AI
Others
TradFi
2026 World Cup
Rewards
Home
Price Prediction
AUPH (Aurinia Pharmaceuticals) Price Prediction
Aurinia Pharmaceuticals

AUPH(Aurinia Pharmaceuticals)

$15.80-6.72%

AUPH(Aurinia Pharmaceuticals) Price Prediction Summary

AI-Generated
As of July 1, 2026, AUPH is currently trading near 16.50, caught between mixed near-term technicals and a moderately bullish sentiment/structure backdrop. The 50-day and 200-day moving averages support upside, while the 20-day MA suggests consolidation; RSI is neutral and MACD remains positive but softening. Sentiment data points bullish—very low IV rank, strong call bias, and a 17.00 analyst target all align with optimism. Structurally, 60\% institutional ownership and minimal short interest reinforce a long-friendly setup. The main uncertainty is whether the technical divergence signals a genuine pullback or simply a pause in a climbing trend; RSI and the 16.00–16.50 zone will be critical to watch. Key levels: 17.00 \(target/resistance\) and 15.50 \(support\). Overall lean is mildly bullish conditional on technical confirmation above 16.75.
Technical Indicators
Mixed Bullish Signal

Daily chart shows conflicting signals with MA50/MA200 supporting upside while MA20 and MACD argue caution.

Market Sentiment
Moderately Bullish

Very low IV rank and strong call bias point to underlying optimism despite muted volatility expectations.

Market Structure
Institutional Strength

High institutional ownership and very low short float create a structurally favorable backdrop for upside.

Key Trading Levels

How Gate Predicts AUPH(Aurinia Pharmaceuticals) Price

Multi-Source Data Collection

Three independent data sources—technical indicators, market sentiment, and market structure signals—are integrated in real time, covering price behavior, trader behavior, and supply-demand dynamics, ensuring the analysis does not rely on a single dimension.

Independent Analysis by Dimension

Technical indicators are used to identify trends and structural positions, market sentiment is used to assess risk appetite, and market structure signals are used to identify supply-demand and positioning changes. Each dimension independently generates signals within its most appropriate time frame.

Cross-Validation of Composite Signals

When signals across multiple dimensions align, confidence in the assessment increases; when signals diverge, it indicates a transitional or consolidation phase, helping to avoid being misled by a single indicator.

Technical Indicators

AI-GeneratedAs of July 1, 2026, **AUPH technical analysis** reveals a fragmented setup across the daily timeframe. The 50-day and 200-day moving averages sit at 16.00 and 14.78 respectively, both aligned in a buy posture and suggesting intermediate-term support for the uptrend. However, the 20-day MA at 16.52 has rolled over into sell territory, indicating near-term consolidation or mild pullback pressure. The MACD level stands at 0.3652 and carries a sell tag, yet remains positive—a sign that momentum has not fully rolled, though its peak may be in. RSI at 48.4 is neutral, neither overbought nor oversold, leaving room for directional movement in either direction. The divergence between the longer-term buy signals \(MA50/MA200\) and the shorter-term hesitation \(MA20/MACD\) suggests AUPH price forecast is in a transition phase rather than a clean trend. Watch the 16.50–17.00 resistance band and the 15.50–16.00 support zone closely for the next directional cue.
IndicatorValueSignal
Exponential Moving Average (10)16.8461
Sell
Exponential Moving Average (100)15.568
Buy
Exponential Moving Average (20)16.5934
Sell
Exponential Moving Average (200)14.458
Buy
Exponential Moving Average (30)16.381
Sell
Exponential Moving Average (50)16.0884
Sell
Hull Moving Average (9)16.4916
Sell
Ichimoku Base Line (9, 26, 52, 26)17.1075
neutral
Moving Averages Summary—
neutral
Simple Moving Average (10)17.122
Sell
Simple Moving Average (100)15.39
Buy
Simple Moving Average (20)16.5045
Sell
Simple Moving Average (200)14.7794
Buy
Simple Moving Average (30)16.144
Sell
Simple Moving Average (50)15.9998
Buy
Volume Weighted Moving Average (20)16.8959
Sell
Average Directional Index (14)25.8164
Sell
Awesome Oscillator1.0418
neutral
Bull Bear Power-0.4344
Sell
Commodity Channel Index (20)-16.3948
neutral
MACD Level (12, 26)0.3452
Sell
Momentum (10)-0.17
Sell
Oscillators Summary—
neutral
Relative Strength Index (14)46.3083
neutral
Stochastic %K (14, 3, 3)29.9824
neutral
Stochastic RSI Fast (3, 3, 14, 14)9.568
neutral
Ultimate Oscillator (7, 14, 28)41.291
neutral
Williams Percent Range (14)-84.6561
neutral
Technical Summary—
neutral

Market Sentiment

AI-GeneratedAs of July 1, 2026, **AUPH market sentiment** leans moderately bullish on the back of compressed volatility and call-option strength. The IV rank sits at just 14.01 out of 100, indicating that realized volatility is near historical lows for this stock—a backdrop that typically constrains option premiums but can also reflect complacency or lack of fear among market participants. The put/call ratio of 0.1654 is exceptionally low, showing that call volume significantly outweighs put volume, a classic signal of bullish positioning by traders. Meanwhile, the mean analyst target price stands at 17.00, offering implicit upside from levels near 16.50. The AUPH price outlook among the options market thus reads as optimistic, though the compressed IV suggests conviction may lack intensity. Market participants are leaning long, but the absence of volatility expansion means enthusiasm is not yet feverish. Watch whether IV rank rises above 20–25 as a potential shift in sentiment, and track whether the put/call ratio stays compressed or begins to normalize.
Analyst Rating
17.0000
Options Put/Call Ratio
11.6300%
Implied Volatility (IV)
12.5270

Market Structure

AI-GeneratedAs of July 1, 2026, **AUPH market structure** reveals a positioning setup that favors longer-term holders and institutions. Institutional investors control 60.26\% of the float, a commanding majority that typically implies steady accumulation or conviction-based holding rather than speculative churn. The short interest sits at just 7.97\% of float, well below the levels that would signal major bearish positioning or elevated short squeeze risk. With a float of 126.2 million shares, the absolute short position remains modest in context. This stock outlook from a structural lens shows minimal forced covering pressure but substantial institutional stewardship. The high institutional ratio combined with low short float creates a stable foundation that can support gradual appreciation. Monitor changes in institutional holding ratios through quarterly filings and track whether short interest begins to climb, which would alter the structural calculus.
Float Shares
126239258.0000
Short % of Float
0.0797
Institutional Holding
0.6026

Influencing Factors

Corporate Earnings and Profit Growth

Revenue, net profit, and forward guidance are the core factors affecting stock prices.

Industry Competition Landscape and Market Share

Changes in a company's competitiveness within the industry and its market share will impact its long-term valuation.

Overall Market Valuation and Interest Rate Environment

When interest rates rise or overall market valuations are elevated, individual stocks are more likely to experience pullbacks.

Institutional Funds and Market Sentiment

Large-scale institutional inflows or outflows, along with changes in market risk appetite, can amplify stock price volatility.

Learn More About AUPH (Aurinia Pharmaceuticals)

No data yet

FAQ

What data is used to generate the AUPH(Aurinia Pharmaceuticals) price prediction?

x

AUPH(Aurinia Pharmaceuticals) price prediction is typically based on three types of data: technical indicators (e.g., RSI, MACD, moving averages), market sentiment (e.g., capital flows and derivatives data), and market structure signals (e.g., positioning and supply-demand changes). Multi-dimensional data is used to enhance the completeness of the analysis.

How do supply and demand affect the AUPH(Aurinia Pharmaceuticals) price prediction?

x

How are technical indicators used in the AUPH(Aurinia Pharmaceuticals) price prediction?

x

What role does market sentiment play in the AUPH(Aurinia Pharmaceuticals) price prediction?

x

What common factors can influence the AUPH(Aurinia Pharmaceuticals) price prediction?

x

How can price predictions be used to assess the current market state of AUPH(Aurinia Pharmaceuticals)?

x

Disclaimer

Gate only provides trade execution services. Any information, reports, opinions, comments, or other materials obtained from Gate, its employees, Gate-provided analytical tools, or third-party research do not constitute investment advice and should not be relied upon for investment decisions. You agree to do your own research and verify external information sources before making any investment. You further agree that Gate shall not be held liable for any loss or damage (including but not limited to loss of profits) arising directly or indirectly from the use of or reliance on such information. Nothing contained in any reports shall be interpreted as an explicit or implied promise, guarantee, or indication of profit, nor does it guarantee that losses can be limited or avoided. Please also note that data related to traditional finance such as forex and CFDs (e.g., real-time prices) displayed on this page is sourced from third parties, is provided for reference only, and is offered on an "as-is" basis without any representations or warranties of any kind, express or implied. Any third-party website links provided are not under Gate's control. Gate assumes no responsibility for the reliability or accuracy of such third-party websites or their content. For further details, please refer to our User Agreement.

Risk Warning

Traditional finance such as forex and CFDs may experience significant price fluctuations. Past performance is not a reliable indicator of future results. The vast majority of retail client accounts incur losses when trading forex and CFDs. Please ensure you fully understand how forex and CFDs operate and assess whether you are able to bear the risk of substantial losses. Even with stop-loss orders, your losses may exceed your initial deposit. Therefore, you should not engage in speculative trading with funds you cannot afford to lose, and you should ensure you are fully aware of the risks involved. The information provided by Gate is general in nature and does not take into account your investment objectives, financial situation, or specific needs. The content and prices on this website must not be interpreted as personal investment advice. Please ensure you fully understand the risks involved and seek independent professional advice where necessary. Gate reserves the right to terminate services at its sole discretion at any time. Gate is not liable for any losses resulting from such termination, including losses caused by closing positions at unfavorable market prices or forced liquidation. For more information, please refer to our Risk Disclosure.